A detailed history of Roxbury Financial LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Roxbury Financial LLC holds 264 shares of LLY stock, worth $269,728. This represents 0.26% of its overall portfolio holdings.

Number of Shares
264
Previous 240 10.0%
Holding current value
$269,728
Previous $183 Million 55.14%
% of portfolio
0.26%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 05, 2026

BUY
$799.57 - $1025.28 $19,189 - $24,606
24 Added 10.0%
264 $284 Million
Q3 2025

Oct 01, 2025

BUY
$625.65 - $812.69 $33,159 - $43,072
53 Added 28.34%
240 $183 Million
Q2 2025

Jul 07, 2025

BUY
$713.71 - $898.95 $54,955 - $69,219
77 Added 70.0%
187 $146 Million
Q1 2025

Apr 09, 2025

BUY
$725.72 - $929.72 $725 - $929
1 Added 0.92%
110 $101 Million
Q4 2024

Jan 30, 2025

BUY
$727.2 - $932.06 $79,264 - $101,594
109 New
109 $87.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Roxbury Financial LLC Portfolio

Follow Roxbury Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roxbury Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roxbury Financial LLC with notifications on news.